Carson Michael A 4

What Happened

• Michael A. Carson, Group President, Medicare & Specialty at Centene, reported a disposition of 604.004 units (derivative/phantom stock) on May 29, 2026. The units were recorded at $59.60 each for a total value of $35,999. The filing lists the transaction as a discretionary transaction (code "I").
• This was not an open‑market sale of Centene shares but a reallocation of units under Centene’s nonqualified deferred compensation plan (see details below).

Key Details

• Transaction date: 2026-05-29; Filed with SEC: 2026-06-02.
• Price/value: 604.004 units × $59.60 = $35,999.
• Transaction code: I (discretionary).
• Shares/units owned (reported context): ownership includes 113,747 previously‑granted restricted stock units and performance stock units (PSUs reported at target).
• Notable footnotes:
  • F3: The transaction reflects a reallocation from an investment option tracking the company’s common stock to an alternative investment option — not an open market sale. It was effected at the closing price on the transaction date.
  • F2/F4: The “phantom stock” units represent rights to receive the fair market value of one share each, have no formal expiration, and will be settled in cash or other non‑Company securities upon termination or at an elected date.

Context

• Because this was a reallocation of deferred compensation/phantom stock (not a cash sale on the market), it should not be interpreted the same way as an open‑market insider sale. No inference about the insider’s view of the company’s prospects should be drawn from this administrative change.